| 17.69 -0.06 (-0.34%) | 12-05 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 20.81  |
1-year : | 24.31 |
| Resists | First : | 17.81 |
Second : | 20.81 |
| Pivot price | 16.71 |
|||
| Supports | First : | 15.73 |
Second : | 14.43 |
| MAs | MA(5) : | 17.36 |
MA(20) : | 16.33 |
| MA(100) : | 19.11  |
MA(250) : | 18.6 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 97.6 |
D(3) : | 96.4 |
| RSI | RSI(14): 67.1 |
|||
| 52-week | High : | 24.1 | Low : | 14.36 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ NEOG ] has closed below upper band by 6.9%. Bollinger Bands are 17.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 17.83 - 17.92 | 17.92 - 17.98 |
| Low: | 17.18 - 17.3 | 17.3 - 17.38 |
| Close: | 17.52 - 17.7 | 17.7 - 17.82 |
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Tue, 05 Dec 2023
Neogen announces biosecurity partnership with Terranova (NASDAQ:NEOG) - Seeking Alpha
Tue, 05 Dec 2023
Neogen® Announces Biosecurity Partnership with TerraNova - PR Newswire
Fri, 01 Dec 2023
Neogen (NEOG) Unveils New Assay for Walnut Allergens Detection - Yahoo Finance
Thu, 30 Nov 2023
Neogen® Launches Highly Sensitive Quantitative ELISA Assay for the Detection of Walnut Allergens - PR Newswire
Tue, 21 Nov 2023
Neogen® to Participate in the Piper Sandler 35th Annual Healthcare Conference - PR Newswire
Fri, 17 Nov 2023
Neogen's (NEOG) Innovation Aids, Currency Headwind Stays - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Diagnostics & Research
|
|
| Shares Out | 216 (M) |
| Shares Float | 216 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 102.7 (%) |
| Shares Short | 13,470 (K) |
| Shares Short P.Month | 10,080 (K) |
| EPS | -0.16 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 14.55 |
| Profit Margin | -2.9 % |
| Operating Margin | 9 % |
| Return on Assets (ttm) | 2.2 % |
| Return on Equity (ttm) | -1.4 % |
| Qtrly Rev. Growth | 73 % |
| Gross Profit (p.s.) | 1.89 |
| Sales Per Share | 4.24 |
| EBITDA (p.s.) | 0.97 |
| Qtrly Earnings Growth | -85.6 % |
| Operating Cash Flow | 78 (M) |
| Levered Free Cash Flow | 45 (M) |
| PE Ratio | -110.57 |
| PEG Ratio | 3 |
| Price to Book value | 1.21 |
| Price to Sales | 4.16 |
| Price to Cash Flow | 48.94 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|